<DOC>
	<DOCNO>NCT00275262</DOCNO>
	<brief_summary>Phase 2 study , conduct patient Hodgkin 's disease , non-Hodgkin 's lymphoma , multiple myeloma , mantle cell lymphoma undergoing high-dose chemotherapy autologous stem cell transplantation .</brief_summary>
	<brief_title>A Study Evaluate Ability Lupron Depot Enhance Immune Function Following Bone Marrow Transplantation</brief_title>
	<detailed_description>This Phase 2 study conduct patient Hodgkin 's disease , non-Hodgkin 's lymphoma , multiple myeloma , mantle cell lymphoma undergoing high-dose chemotherapy autologous stem cell transplantation . Patients randomize receive either LAD 11.25 mg 3 Month treatment placebo patient vaccinate KLH 6 month posttransplant . Patients evaluated determine rate immunologic recovery LAD group enhance compare placebo group .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>1 . Must female age 18 50 female &gt; 50 year old estradiol concentration level &gt; = 30 pg/mL follicle stimulate hormone level &lt; 40 mIU/mL , male age 1865 ( inclusive ) . 2 . Must Hodgkin 's disease , nonHodgkin 's lymphoma , multiple myeloma , mantle cell lymphoma consider appropriate candidate hematopoietic stem cell transplant . 1 . Multiple myeloma patient partial complete response chemotherapy . 2 . Patients Hodgkin 's disease nonHodgkin 's lymphoma achieve partial response initial chemotherapy first second chemosensitive relapse , achieve complete partial response salvage treatment . Patients first remission mantle cell lymphoma , intermediate high grade lymphoma , present high intermediate high IPI ( International Prognostic Index ) score also eligible . 3 . Must seronegative hepatitis C HIV . 4 . Must receive prior tetanus immunization 5 . Must receive prior KLH immunization . 6 . Must ECOG performance status ( PS ) &lt; = 1 Karnofsky PS &gt; = 70 % . 7 . Must creatinine &lt; = 2.0 mg/dL ; ejection fraction &gt; 45 % ; carbon monoxide diffusion lung ( DLCO ) &gt; 50 % predict ; serum bilirubin &lt; 1.5 time upper limit normal unless Gilbert 's syndrome , SGPT &lt; 3 time normal value . 8 . Must 3 week prior surgery ( except central line placement ) fully recover effect surgery . 9 . Must absolute neutrophil count ( ANC ) &gt; = 1,500 µL , platelet count &gt; = 100,000/µL hemoglobin &gt; = 8.0 gm/dL within 21 day prior randomization . 10 . Must able return clinical site followup visit . 11 . Must able provide write consent . 1 . Must uncontrolled lifethreatening infection ( active infectious process require intravenous [ IV ] systemic medical therapy within 1 week prior study enrollment ) . 2 . Must diagnose suspect schistosomiasis infection . 3 . Must previously receive hematopoietic stem cell transplantation . 4 . Must require tandem transplant . 5 . Must female positive pregnancy test , pregnant , lactate breast feeding , wish become pregnant course study . Must agree use barrier method contraception . 6 . Must receive estrogen testosterone replacement therapy , phytoestrogen , phytotestosterone , oral contraceptive ( patient may enroll oral contraceptive cease prior study entry ) , administer Depo Provera within 3 month enter study . 7 . Must prior mediastinal sternal radiation . 8 . Must receive investigational drug antibiotic within 3 week prior study drug administration schedule receive investigational drug course study . 9 . Must unstable cardiac arrhythmia , uncontrolled congestive heart failure , history myocardial infarction ( MI ) ischemia , stroke , embolic event within 6 month study start . 10 . Must medical psychiatric condition , opinion investigator , would compromise patient 's ability participate study . 11 . Must receive plan receive palifermin ( KGF ) . 12 . Must allergy shellfish . 13 . Must previously take GnRH analog within 18 month . 14 . Must woman undergone bilateral oophorectomy , man orchiectomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Bone marrow transplantation</keyword>
	<keyword>Hematopoietic stem cell transplantation</keyword>
	<keyword>Hodgkin 's disease</keyword>
	<keyword>non-Hodgkin 's lymphoma</keyword>
	<keyword>multiple myeloma</keyword>
</DOC>